Primary tabs

Human Polyomavirus BKV as a HIV Vaccine Vector

BK virus is a very common and non-pathogenic virus that persists in specific organs for long periods of time. Simon Lacey of Beckman Research Institute of the City of Hope in the U.S. proposes using an engineered BK virus as a vaccine vector to introduce HIV polyepitope sequences in hopes of inducing a strong and long- lasting immune response against HIV.

Grant ID
OPP52812
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False